Quantification of Human Adipogenesis
|ClinicalTrials.gov Identifier: NCT01257997|
Recruitment Status : Completed
First Posted : December 10, 2010
Last Update Posted : January 29, 2018
|Condition or disease||Intervention/treatment|
|Healthy||Biological: 15N-Thymidine, 2H-Water|
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Quantification of Human Adipogenesis|
|Study Start Date :||December 2010|
|Actual Primary Completion Date :||December 2016|
|Actual Study Completion Date :||January 2017|
18-49 year old healthy men and women. Free of significant chronic medical illness and illicit substance abuse. Body mass index from 20 to 27.
Biological: 15N-Thymidine, 2H-Water
Stable isotope 15N-thymidine, infused IV (15mg/hour) for 72 hours (phase 1 pilot).
Stable isotope 2H-water, ingested by mouth once per day for 3 days (phase 1 pilot) or 28 days (phase 2 pilot).
- Quantifying human adipogenesis-counting the number of new fat cells. [ Time Frame: 4 weeks-7 months ]
Biospecimen Retention: Samples Without DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01257997
|United States, Massachusetts|
|Brigham and Women's Hospital|
|Boston, Massachusetts, United States, 02115|
|Principal Investigator:||Matthew L Steinhauser, MD||Brigham and Women's Hospital|